Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
Chart calendar Shanghai Henlius Biotech, Inc.
Upcoming events on Shanghai Henlius Biotech, Inc.
Past events on Shanghai Henlius Biotech, Inc.
21/03/2024 11:47 | Q4 2023 Earnings Release |
15/11/2023 12:10 | Q3 2023 Earnings Release |
28/08/2023 08:30 | Extraordinary Shareholders Meeting |
25/08/2023 12:26 | Q2 2023 Earnings Release |
25/05/2023 07:00 | Annual General Meeting |
30/03/2023 | Q4 2022 Earnings Release |
17/08/2022 | Interim 2022 Earnings Release |
15/03/2022 | FY 2021 Earnings Release |
28/09/2021 08:00 | Chinese Society of Clinical Oncology Meeting - Zhenggang Ren, Zhongshan Hospital |
26/09/2021 10:15 | Chinese Society of Clinical Oncology Meeting - Ye Guo, Shanghai East Hospital |
26/09/2021 08:24 | Chinese Society of Clinical Oncology Meeting - Jusheng An Cancer Hospital Chinese Academy of Medical |
26/09/2021 03:27 | Chinese Society of Clinical Oncology Meeting - Ye Guo Shanghai East Hospital |
17/08/2021 | Interim 2021 Earnings Release |
19/01/2021 | UBS Greater China Conference |
13/01/2021 | Citigroup Greater China Healthcare Corporate Day |
12/01/2021 | JP Morgan Healthcare Conference |
23/08/2020 | Interim 2020 Earnings Release |
12/06/2020 08:30 | Extraordinary Shareholders Meeting |
22/03/2020 | FY 2019 Earnings Release |
19/02/2020 01:00 | Extraordinary Shareholders Meeting |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 90,9 107 -15.35% | 588 584 0.67% | 1 682 1 530 9.98% | 3 215 3 039 5.8% | 5 395 5 075 6.29% | 5 875 |
EBITDA Million CNY | Released Forecast Spread | -769 -619 -24.21% | -858 -695 -23.4% | -420 -438 4.21% | -311 165 -288.25% | 1 021 873 17% | 1 083 |
EBIT Million CNY | Released Forecast Spread | -851 -651 -30.74% | -994 -792 -25.51% | -620 -606 -2.37% | -324 -640 49.41% | 662 594 11.37% | 751 |
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | -875 -536 -63.21% | -994 -792 -25.41% | -957 -678 -41.2% | -694 -365 -90.13% | 570 479 18.88% | 663 |
Net income Million CNY | Released Forecast Spread | -875 -607 -44.22% | -994 -765 -29.82% | -984 -678 -45.23% | -695 -366 -89.99% | 546 466 17.26% | 594 |
EPS CNY | Released Forecast Spread | -1,76 -1,30 -34.95% | -1,88 -1,50 -25.48% | -1,83 -1,19 -53.98% | -1,28 -0,74 -72.97% | 1,00 0,86 16.06% | 1,10 |
Announcement Date | 23/03/20 | 26/03/21 | 16/03/22 | 31/03/23 | 21/03/24 | - |
11/07/2024 07:00 | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
15/07/2024 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
22/07/2024 | BIOGEN INC.: Q2 2024 Earnings Release (Projected) |
23/07/2024 07:00 | BIOGAIA AB: Q2 2024 Earnings Release |
23/07/2024 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
24/07/2024 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
24/07/2024 | GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected) |
25/07/2024 06:00 | UCB: Q2 2024 Earnings Release |
25/07/2024 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
29/07/2024 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Shanghai Henlius Biotech, Inc.
14/05/2024 16:35 | GRIFOLS, S.A.: Q1 2024 Earnings Release |
12/05/2024 | ALTEOGEN INC.: Q1 2024 Earnings Release (Projected) |
09/05/2024 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
09/05/2024 | MEDY-TOX INC.: Q1 2024 Earnings Release |
09/05/2024 21:05 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
09/05/2024 21:05 | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
09/05/2024 07:30 | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
08/05/2024 | HUGEL, INC.: Q1 2024 Earnings Release |
08/05/2024 21:16 | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
08/05/2024 21:05 | ZAI LAB LIMITED: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 2696 Stock
- SGBCF Stock
- Calendar Shanghai Henlius Biotech, Inc.